Cargando…

Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China

BACKGROUND: The prevalence of hyperuricemia (HUA) and gout continues to increase in China. Research suggests that HUA may be related to many diseases other than gout. However, further population research is required to investigate the association between HUA and metabolic syndromes. This study sough...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Shuguang, Jiang, Qiang, Sun, Pei, Li, Yi, Zhu, Yanhua, Liu, Jin, Ye, Xiaoran, Chen, Ting, Zhao, Fei, Yang, Wenjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576711/ https://www.ncbi.nlm.nih.gov/pubmed/34790756 http://dx.doi.org/10.21037/atm-21-5052

Ejemplares similares

The prevalence of hyperuricemia in China: a meta-analysis
por: B, Liu, et al.
Publicado: (2011)

Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China
por: Song, Peige, et al.
Publicado: (2018)

Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study
por: Zhao, Yannan, et al.
Publicado: (2021)

Real-world data on severe lung cancer: a multicenter retrospective study
por: Wang, Fei, et al.
Publicado: (2023)

Prevalence and Causes of Hyperuricemia in Children
por: Kumar, Jatender, et al.
Publicado: (2021)

Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis
por: Yang, Ping, et al.
Publicado: (2023)

A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China
por: He, Dalin, et al.
Publicado: (2019)

Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study
por: Feng, Qian, et al.
Publicado: (2021)

Changes in the prevalence of hyperuricemia in clients of health examination in Eastern China, 2009 to 2019
por: She, Dunmin, et al.
Publicado: (2022)

Prevalence of Albuminuria in Cardiology and Endocrinology Departments and Its Influencing Factors: A Multicenter, Real-World Evidence Study in China
por: Ren, Qian, et al.
Publicado: (2020)

Prevalence of hyperuricemia and the population attributable fraction of modifiable risk factors: Evidence from a general population cohort in China
por: He, Huijing, et al.
Publicado: (2022)

Clinical Features of Extragastrointestinal Stromal Tumor Compared with Gastrointestinal Stromal Tumor: A Retrospective, Multicenter, Real-World Study
por: Feng, Huolun, et al.
Publicado: (2021)

Hyperuricemia is associated with atrial fibrillation prevalence in very elderly - a community based study in Chengdu, China
por: Huang, Gang, et al.
Publicado: (2018)

The prevalence of gout and hyperuricemia in middle-aged and elderly people in Tibet Autonomous Region, China: A preliminary study
por: Zhang, Qingxi, et al.
Publicado: (2020)

The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
por: Ye, Byong Duk, et al.
Publicado: (2021)

The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China
por: Zhang, Xin, et al.
Publicado: (2018)

Prevalence of hyperuricemia and its related risk factors among preschool children from China
por: Li, Nan, et al.
Publicado: (2017)

Prevalence and Risk Factors Associated with Hyperuricemia in the Pearl River Delta, Guangdong Province, China
por: Liu, Weiqi, et al.
Publicado: (2021)

Nomogram for the Prediction of Intrahospital Mortality Risk of Patients with ST-Segment Elevation Myocardial Infarction Complicated with Hyperuricemia: A Multicenter Retrospective Study
por: Bai, Zhixun, et al.
Publicado: (2021)

Treatment outcomes of secukinumab in adult patients with moderate‐to‐severe plaque psoriasis in China: A real‐world multicenter retrospective study
por: Ding, Yangfeng, et al.
Publicado: (2023)

Revalidation of the ATTRACTION-4 study in a real-world setting: a multicenter, retrospective propensity score matching study in China
por: Dai, Yuhong, et al.
Publicado: (2023)

Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study
por: Nasr, Fadi, et al.
Publicado: (2021)

Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study
por: Ollivier, Luc, et al.
Publicado: (2022)

Diagnosis and treatment of uterine sarcoma: A multicenter, real-world study in western China
por: Li, Kemin, et al.
Publicado: (2021)

Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study
por: Sun, Chuandong, et al.
Publicado: (2021)

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
por: Shi, Yuankai, et al.
Publicado: (2017)

Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study
por: Xu, Yu, et al.
Publicado: (2022)

Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China
por: Yang, Jing, et al.
Publicado: (2022)

The Prevalence of Hyperuricemia and Its Correlates among Adults in China: Results from CNHS 2015–2017
por: Piao, Wei, et al.
Publicado: (2022)

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2020)

Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China
por: Li, Jin, et al.
Publicado: (2023)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
por: Lebel, Eyal, et al.
Publicado: (2023)

Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
por: Kühne, Fabienne, et al.
Publicado: (2023)

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy
por: Di Gregorio, Carlo, et al.
Publicado: (2023)

RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD
por: Koblizek, Vladimir, et al.
Publicado: (2023)

Real-World, Multicenter Case Series of Patients Treated with Isavuconazole for Invasive Fungal Disease in China
por: Wu, Lisha, et al.
Publicado: (2023)

High prevalence and low awareness of hyperuricemia in hypertensive patients among adults aged 50–79 years in Southwest China
por: Zhang, Yang, et al.
Publicado: (2022)

Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study
por: Liu, Xiao zhu, et al.
Publicado: (2023)

A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China
por: Gu, Zhen-Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8r19qqkpr7mq6bnjgfec2ifo6